ABSTRACTS:

IN VIEW OF MANY REQUESTS DUE TO THE HOLIDAYS, THE DEADLINE FOR SUBMISSION OF ABSTRACTS AND REGISTRATION WITH REDUCED FEE HAS BEEN POSTPONED TO

FRIDAY, AUGUST 8 TH



General Information

• Abstracts in English, will only be accepted on-line and submitted by July 31th, 2008

• No abstracts will be accepted after this deadline. The Organizing Committee reserves the right to refuse any abstracts written in inadequate English or containing ortographic errors.

• Submissions will be analyzed by the Scientific Committee, according to directions from the Organizing Committee. This Committee will verify the adequacy of the abstracts for presentation at the congress and publication in the annals (print or CD).

• The best abstracts will be selected for oral presentation during “Express Presentation”
Sessions.

• The criteria for selection will be both scientific quality and the degree of general interest. Upon selection, the first author presenting the study should be a graduate student or post-doctoral.

• A maximum of two abstracts will be accepted per presenting author. The author presenting the study will be required to register for the Congress. Please register before the abstract submission deadline, July 31th, 2008

• All abstracts will be scheduled for poster presentation.

• Only one certificate will be issued per abstract, stating the names of all authors and co-authors.

Attention: Enter the information on the form and registration (Title, authors), in the order you wish them to appear on the certificate.


Format

Justify all text to left margin.

Title: FULL TITLE IN CAPITAL BOLD LETTERS

Author(s): FULL NAME OF AUTHORS IN CAPITAL LETTERS, with the presenting author in bold. The presenting author’s name should be underlined (same name as on the registration form). Names should be separated by a semicolon. Each name should be followed by the superscript number related to the affiliation.

Institution: Superscript number followed institution name

Text: Subheadings (introduction, objectives, method, etc ) in bold

Footnote: Indicate sources of financial support

Abstracts not complying with the above specifications will not be accepted. Special attention should be given to written English, as abstracts containing spelling, orthographic or grammatical mistakes will be rejected. A template is included below.



Abstract Elaboration

Software: Microsoft Word
Maximum 2500 characters (Including spaces) for all subheadings.

Margins: right 2 cm and left 3 cm

Font: Arial 12, normal style, use "symbol" font for special characters. Single line spacing and no paragraph divisions.

Insert a single line between: title and author; authors and institution; institution and text.

Abstract Submission

Submit your abstracts on-line by 31/7/2008 through the website www.oxfordeventos.com.br/sbi2008, classified by one of the areas listed below:

1. Chemokines and Trafficking (CT)
2. Cellular Immunology (CE)
3. Clinical Immunology (CL)
4. Immunoregulation (IR)
5. Immunopharmacology (IP)
6. Immunology of Infectious and Parasitic Diseases (ID)
7. Innate Immunity (IN)
8. Humoral Immunology (HI)
9. Molecular Immunology (MI)
10. Tumor Immunology (TU)
11. Transplantation and Immunogenetics (TR)
12. Vaccines (VC)
13. Others (OT)

Model

TITLE

COMPLETE NAME OF THE MAIN AUTHOR(IC)(1); COMPLETE NAME OF THE
AUTHOR(PG)(2); MÁRCIA GONÇALVES(PG)(1)

(1).Institution; (2).Institution

Text: Specify the following order: Introduction, Objective, Methodology, main Results and Conclusions Introduction and Objectives: An Introduction to the subject and objectives of the work. Bibliographic citations must be in accordance to the following model: Am.J.Med.Sci. 183: 90-94, 1932. (No authors)
Methods and Results: This item must contain a brief description of the methods used in the work and the corresponding results. It is important that the results are expressed as means ± variances (standard deviation, standard error, etc). Values for “n” should also be given. Only abstracts in standard written English will be accepted.
Conclusion: The abstract must end with a brief conclusion.
Financial support: Use the last line of the abstract to acknowldege financial support


Abstract Evaluation

• Abstracts will be selected by the Scientific Committee, based on the criteria outlined.

• The abstract should state the study objectives, briefly describing the methods used and results and conclusions reached.

• Quantitative abstracts will not be accepted without numerical data (e.g. mean and standard deviation, control percentage etc). Citations referring to bibliographic references in abstracts follow different criteria from those used in full articles. Citations should be restricted to a minimum (no author names) and, if necessary, the abbreviated journal title should be used, followed by volume: first page-last page, year (e.g. Brain Res. 472:24-40, 1992). Citations like (Ashley et al., 1994) will not be accepted.

• Abstracts should comply with the guidelines provided above and be submitted in a format that permits adequate graphical reproduction. In cases of non-compliance to the list of items below, a revised versions of abstracts will be considered. Subsequent acceptance will be at the discretion of the Scientific Committee.

1. Area related to Immunology.
2. General interest of abstract theme.
3. Ethical clearance (research on humans and laboratory animals)
4. Language.
5. Definition of study material.
6. Definition of terms used.
7. Clear result description.
8. Conclusion outside the limitations of the results.
9. Conclusion supported by the results.

Approval and Rules

The acceptance letter for the approved abstract will be available on the website www.oxfordeventos.com.br/sbi2008 as from September 22th, 2008, including all necessary information and rules.